Browsing by Author Disel, Umut
Showing results 1 to 1 of 1
Issue Date |
Title |
Author(s) |
Jul-2021 |
Results from RATIONALE 303: A global phase 3 study of tislelizumab (TIS) vs docetaxel (TAX) as second- or third-line therapy for patients with locally advanced or metastatic NSCLC. |
Zhou, Caicun;Huang, Dingzhi;Yu, Xinmin;Liu, Yunpeng;Fan, Yun;Shu, Yongqian;Ma, Zhiyong;Wang, Ziping;Cheng, Ying;Wang, Jie;Hu, Sheng;Liu, Zhihua;Dvorkin, Mikhail;Poddubskaya, Elena;Disel, Umut;Akopov, Andrey;Ma, Yiyuan;Wang, Yan;Pan, Zhenyu;Yu, Cunjing;Rivalland, Gareth |